Homes for Sale in East Bay (San Francisco Bay Area)
Real Estate: Antioch, G St homes, Antioch, Hillcrest Ave homes, Antioch, James Donlon Blvd homes, Antioch, Lone Tree Way homes, Berkeley, Ashby Ave homes, Berkeley, Derby St homes, Berkeley, Sacramento St homes, Berkeley, San Pablo Ave homes, Berkeley, Shattuck Ave homes, Berkeley, University Ave homes, Berkeley, Warring St homes, Castro Valley, Crow Canyon Rd homes, Concord, Willow Pass Rd homes, Dublin, Peppertree Rd homes, El Cerrito, San Pablo Ave homes, Fremont, Fremont Blvd homes, Hayward, Harder Rd homes, Hayward, Huntwood Ave homes, Hayward, Mission Blvd homes, Hayward, Tennyson Rd homes, Livermore, Bethany Reservoir homes, Livermore, North Flynn Rd homes, Martinez, Alhambra Ave homes, Moraga, Donald Drive homes, Moraga, Fernwood Drive homes, Newark, Cedar Blvd homes, Oakland, Macarthur Blvd homes, Oakland, Skyline Blvd homes, Oakland, 38th St homes, Oakland, 51st St homes, Oakland, Piedmont Ave homes, Oakland, Shattuck Ave homes, Oakland, 14th St homes, Oakland, 3rd St homes, Oakland, 7th St homes, Oakland, Broadway St homes, Oakland, Lakeshore Ave homes, Oakland, Martin Luther King Jr homes, Oakland, Oak St homes, Oakland, Telegraph Ave homes, Pinole, Pinole Valley Rd homes, San Leandro, Davis St homes, San Leandro, East 14th St homes, Union City, Decoto Rd homes, Union City, Whipple Rd homes, Walnut Creek, Golden Rain Rd homes

World News   USA   Bay Area   South SF   Business   Merger (17)
Homes for Sale in East Bay (San Francisco Bay Area)
South SF, Merger Timeline Saturday, March 20 Bookmark and Share     Author
To sell or purchase a home in South SF click here
Search Bay Area News Atlas:

Roche raises bid for Genentech
World News World Merger (41) USA (229) Bay Area Bay Area Merger (212) South SF (108) Business (40) Merger (17)
2009 (9) 2008 (3) 2007 (1) 2006 (1) 2005 (1) 2001 (2)
   Genentech (15)
Merger on Wikipedia Merger on Web Merger Books
Real Estate

Roche-Genentech deal called close
Big leadership changes at Genentech  Roche named a member of its inner circle as chief executive of Genentech, replacing Arthur Levinson Roche completes purchase of Genentech  Swiss drugmaker completed its acquisition of biotechnology pioneer by sweeping up enough shares through an offer to gain ownership of 93% Roche to take over Genentech for $47B

year 2009 Top ^

Apr.15
Mar.26
Mar.12
  Swiss giant agreed to buy the 44% of biotech pioneer that it doesn't already own, ending a long corporate struggle
 The $95-per-share deal brings Roche all of the sales of cancer drugs as well as its promising research pipeline. The deal offers $95 per share for the 44 percent of Genentech that Roche Holding AG doesn't already own
Mar.9
  Roche is reportedly willing to pay Genentech $95 a share, up from the $93, in what would be a $46.7 billion deal
Mar.6
  Swiss drugmaker increased its offer to $93 per share. Genentech shares shot up to $90.05, gaining $8.41 or 10 percent
Mar.3 Genentech replies to hostile Roche bid  Genentech's management fired off figures about its future growth to persuade investors and analysts that the Swiss drug giant is selling it short Feb.9 Roche launches $86.50-a-share bid
  Genentech: Swiss drugmaker officially launched its $42 billion hostile offer for the 44% of Genentech Inc. it doesn't already own
Feb.6 Roche CEO: Offer for Genentech fair deal  Severin Schwan the company's surprisingly low hostile $86.50-per-share offer is fairly priced and he is confident to get enough financing Jan.30 Roche revives takeover bid of Genentech
  Swiss drugmaker, frustrated by stalled negotiations, plans a hostile takeover at a lower price than the $89 per share rejected in August

year 2008 Top ^

Aug.21 Retention plan to cost $371 million  Genentech: An employee retention plan announced along with its rejection of Roche's buyout offer will cost the biotechnology giant about $371 million Aug.13 Genentech rejects Roche's $43.7b bid  Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid Jul.25 Panel to ponder Roche takeover offer  Genentech: Genentech has set up a committee of independent directors to consider Swiss drugmaker offer to acquire all shares it does not already own

year 2007 Top ^

Aug.3 Genentech completes Tanox acquisition  Genentech Inc. that it has completed the $919 million acquisition of its partner in the development of the asthma drug Xolair

year 2006 Top ^

Nov.11 Genentech to acquire partner Tanox  Genentech Inc. has agreed to its first acquisition ever - Tanox Inc., co-developer of the asthma medicine Xolair

year 2005 Top ^

Sep.23 Genentech Stops Enrolling Avastin Study  The company stopped enrolling patients in a study due to greater occurrences of gastrointestinal perforations

year 2002 Top ^


year 2001 Top ^

Nov.19 Exelixis buys Genomica  Drug company to acquire biotech software company in a $110 million deal Aug.23 Eos Biotechnology to be acquired  Biotech startup will be acquired by Pharmocopeia Inc. in a deal worth $170 million.



Neighbor Real Estate:

Add a favorite (file a bookmark) to South SF, Merger Timeline


Please send feedback to: support@mapreport.com

Advertise on South SF, Merger Page